Envisagenics’ AI platform, SpliceCore®, powers the discovery and therapeutic targeting of RNA splicing — unlocking breakthrough treatments for patients.
Smarter Discovery. Transformative Treatments.
Learn moreLearn more
By combining deep expertise in RNA biology and AI, our approach discovers high-impact, novel therapeutic targets in oncology and neurodegeneration.
We harness the untapped potential of RNA splicing to discover drug targets missed by traditional methods.
Learn moreLearn more
Powered by Science. Driven by People.
We’re a collaborative, patient-driven team dedicated to delivering life-changing treatments.
